Recce Pharmaceuticals Ltd (ASX: RCE) Share Price and News
Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)
() Chart and Price Data
Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range
-
Days Range
-
Turnover
Fundamental Company Figures
Data provided by Morningstar.
Market Cap
$170.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Shares Outstanding
173.78 million
Earnings per share
-0.100
Dividend per share
N/A
Year To Date Return
-3.79%
Earnings Yield
N/A
Franking
N/A
Recce Pharmaceuticals Ltd (ASX: RCE) Latest News
Why Novonix, Recce, Singular Health, & Starpharma shares are storming higher
James Mickleboro | February 12, 2021 11:41am
Why the Recce Pharmaceuticals (ASX:RCE) share price is rocketing 10% higher
James Mickleboro | February 12, 2021 11:14am
Why a2 Milk, Air New Zealand, Mesoblast, & Recce shares are storming higher
James Mickleboro | December 23, 2020 11:15am
Recce (ASX:RCE) share price charges higher on COVID-19 update
James Mickleboro | December 23, 2020 10:15am
Recce (ASX:RCE) share price shoots up 5% on new patent approval
Aaron Teboneras | November 23, 2020 1:42pm
Here’s why the Recce (ASX:RCE) share price has fallen 7% today
Aaron Teboneras | October 21, 2020 4:24pm
The Recce (ASX:RCE) share price has surged up today. Here’s why
Aaron Teboneras | October 16, 2020 12:39pm
Recent Stock Announcements
Price Sensitive OnlyAn announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Show All
| Date | Heading | An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. | Time | Pages | File Size |
|---|---|---|---|---|---|
About Recce Pharmaceuticals Ltd (ASX: RCE)
Recce Pharmaceuticals Ltd (ASX: RCE) is a global biotechnology company engaged in the development and commercialisation of a new class of antibiotics. It operates in only one business segment, being research and development of pharmaceutical drugs.
Based in Australia, the company also has operations in the United Kingdom, and the United States. Recce offers antibiotic drugs to treat diseases caused by various bacterias including sepsis, Helicobacter pylori, Escherichia coli, Pseudomonas aeruginosa, and others.
With COVID-19 in the backdrop of 2020, the Recce share price has been pushing higher in the last 12 months.
Share Price History
Data provided by Morningstar.| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 05 Mar 2021 | $0.98 | $-0.03 | -2.96% | 241,862 | $1.00 | $1.00 | $0.98 |
| 04 Mar 2021 | $1.02 | $-0.02 | -1.93% | 137,898 | $1.04 | $1.04 | $1.00 |
| 03 Mar 2021 | $1.04 | $0.00 | 0.00% | 272,689 | $1.03 | $1.04 | $1.01 |
| 02 Mar 2021 | $1.04 | $0.01 | 0.98% | 159,005 | $1.02 | $1.04 | $1.02 |
| 01 Mar 2021 | $1.03 | $-0.03 | -2.86% | 221,431 | $1.05 | $1.06 | $1.02 |
| 26 Feb 2021 | $1.05 | $-0.02 | -1.87% | 109,095 | $1.07 | $1.07 | $1.04 |
| 25 Feb 2021 | $1.07 | $0.03 | 2.88% | 103,805 | $1.05 | $1.07 | $1.04 |
| 24 Feb 2021 | $1.04 | $-0.01 | -0.95% | 152,658 | $1.06 | $1.06 | $1.03 |
| 23 Feb 2021 | $1.05 | $0.02 | 1.94% | 147,668 | $1.06 | $1.06 | $1.02 |
| 22 Feb 2021 | $1.03 | $0.02 | 1.97% | 111,420 | $1.03 | $1.05 | $1.02 |
| 19 Feb 2021 | $1.02 | $-0.01 | -0.98% | 353,609 | $1.03 | $1.03 | $1.02 |
| 18 Feb 2021 | $1.03 | $-0.02 | -1.92% | 274,340 | $1.09 | $1.09 | $1.03 |
| 17 Feb 2021 | $1.04 | $-0.05 | -4.59% | 341,012 | $1.10 | $1.10 | $1.04 |
| 16 Feb 2021 | $1.09 | $-0.02 | -1.80% | 515,891 | $1.11 | $1.11 | $1.05 |
| 15 Feb 2021 | $1.11 | $-0.01 | -0.89% | 553,999 | $1.13 | $1.14 | $1.09 |
| 12 Feb 2021 | $1.12 | $0.09 | 8.74% | 1,482,780 | $1.10 | $1.15 | $1.06 |
| 11 Feb 2021 | $1.03 | $0.02 | 1.98% | 415,231 | $1.03 | $1.03 | $1.00 |
| 10 Feb 2021 | $1.01 | $-0.01 | -0.98% | 311,295 | $1.03 | $1.04 | $1.00 |
| 09 Feb 2021 | $1.03 | $-0.03 | -2.84% | 265,420 | $1.06 | $1.06 | $1.01 |
| 08 Feb 2021 | $1.06 | $0.00 | 0.00% | 268,463 | $1.03 | $1.06 | $1.00 |
| 05 Feb 2021 | $1.05 | $0.05 | 4.98% | 476,013 | $1.00 | $1.05 | $0.99 |
| 04 Feb 2021 | $1.01 | $-0.02 | -1.95% | 343,473 | $1.04 | $1.05 | $1.01 |
Director Transactions
Data provided by Morningstar.
Show more
Directors & Management
Data provided by Morningstar.
Show more
Top Share Holders
Data provided by Morningstar.| Name | Shares | Capital |
|---|---|---|
| Mr Graham Melrose & Ms Olga Melrose | 36,450,003 | 25.28% |
| Mr Ross Gustafson | 6,988,402 | 4.85% |
| Mr James Graham | 5,238,120 | 3.63% |
| Acuity Capital Investment Management Pty Ltd <Acuity Capital Holdings A/C> | 4,500,000 | 3.12% |
| J P Morgan Nominees Australia Pty Limited | 4,347,169 | 3.02% |
| Ms Michele Keryn Dilizia | 3,141,273 | 2.18% |
| Querion Pty Ltd | 2,100,000 | 1.46% |
| Acewood Investments Pty Ltd <Chivers Super Fund A/C> | 1,646,154 | 1.14% |
| Citicorp Nominees Pty Limited | 1,158,556 | 0.80% |
| Golden Rivers Mining Pty Ltd | 1,154,006 | 0.80% |
| Pejay Pty Limited | 1,100,000 | 0.76% |
| Mr Nikolai Shirobokov & Mrs Svetlana Shirobokov | 1,060,414 | 0.74% |
| Mr Robert Cerny & Mrs Zaphiero John Cerny <Parez Super Fund A/C> | 1,000,000 | 0.69% |
| Shortis Natural Therapies Pty Limited <Shortis Family A/C> | 1,000,000 | 0.69% |
| Mr Leslie John Field & Mrs Eve Field | 938,504 | 0.65% |
| McCray Investments Pty Ltd <McCray Fam SF A/C> | 865,281 | 0.60% |
| Mr Mark David Swinn | 833,105 | 0.58% |
| Mr Christopher James Frisch & Mr Paul Edward Frisch <Fredflint Superfund A/C> | 759,433 | 0.53% |
| Mr Denis Pierre Geoffrey Pyman <Pyman Super Fund A/C> | 700,000 | 0.49% |
| Super And Investment Holdings Pty Ltd <Nettleton Family S/F A/C> | 650,000 | 0.45% |
| Haultain Properties Ltd | 550,000 | 0.38% |
| Arthur Deryck Bray Graham & Nanette Graham | 550,000 | 0.38% |